Literature DB >> 28728696

Percutaneous Edge-to-Edge Repair of Recurrent Severe Mitral Regurgitation After Surgical Mitral Valve Repair.

Daniel Braun, Christian Frerker, Maria Isabel Körber, Oliver Gaemperli, Johannes Patzelt, Ulrich Schaefer, Christoph Hammerstingl, Peter Boekstegers, Ilka Ott, Hüseyin Ince, Holger Thiele, Jörg Hausleiter.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 28728696     DOI: 10.1016/j.jacc.2017.05.045

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  4 in total

1.  Long-term results of the edge-to-edge repair for failed mitral valve repair as a bailout option.

Authors:  Zhaoji Zhong; Ziqi Yue; Zhenhua Zhao; Wu Song; Shanshan Zheng; Sheng Liu
Journal:  Gen Thorac Cardiovasc Surg       Date:  2020-07-11

2.  Treatment of severe mitral regurgitation that mimics a para-ring mitral regurgitation after failed annuloplasty ring with MitraClip: A case report.

Authors:  Hesham Abdo Naeim; Osama Alamodi; Waleed Saeed; Abeer Mahmood; Lamiaa Khedr; Ramy ELRowiny; Reda Abuelatta
Journal:  J Saudi Heart Assoc       Date:  2020-04-17

3.  What Can We Expect From MitraClip After Failed Surgical Mitral Repair?

Authors:  Donald Glower
Journal:  J Am Heart Assoc       Date:  2021-04-02       Impact factor: 5.501

4.  MitraClip After Failed Surgical Mitral Valve Repair-An International Multicenter Study.

Authors:  Zouhair Rahhab; David Scott Lim; Stephen H Little; Maurizio Taramasso; Shingo Kuwata; Matteo Saccocci; Corrado Tamburino; Carmelo Grasso; Christian Frerker; Theresa Wißt; Ross Garberich; Jörg Hausleiter; Daniel Braun; Eleonora Avenatti; Victoria Delgado; Gian Paolo Ussia; Fausto Castriota; Roberto Nerla; Hüseyin Ince; Alper Öner; Rodrigo Estevez-Loureiro; Azeem Latib; Damiano Regazzoli; Nicolo Piazza; Hind Alosaimi; Peter P T de Jaegere; Jeroen Bax; Danny Dvir; Francesco Maisano; Paul Sorajja; Michael J Reardon; Nicolas M Van Mieghem
Journal:  J Am Heart Assoc       Date:  2021-04-02       Impact factor: 5.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.